miR-21 targets Fas ligand-mediated apoptosis in breast cancer cell line MCF-7

Abstract

Over-expression of Fas ligand (FasL) on tumor cell surface can induce the apoptosis of specific activated tumor infiltrating lymphocytes (TILs) via the Fas/FasL pathway, leading to the formation of a site of immune privilege surrounding the tumor mass for escaping immune surveillance and promoting tumor proliferation, invasion and metastasis. The blocking effect of miR-21 on FasL-mediated apoptosis in breast cancers was investigated in this study. The expression levels of miR-21 and FasL in human breast carcinoma cell lines were detected by using RT-PCR and Western blotting. FasL as a target gene of miR-21 was identified by Luciferase assay. The apoptosis of Jurkat T lymphocytes induced by MCF-7 cells was determined by flow cytometry. It was found that in four human breast cancer cell lines, FasL expression level in MCF-7 cells was the highest, while miR-21 was down-regulated the most notably. After miR-21 expression in MCF-7 cells was up-regulated, FasL was identified as a target gene of miR-21. When the effector/target (E/T) ratio of MCF-7 cells and Jurkat cells was 10:1, 5:1 and 1:1, the inhibitory rate of apoptosis of Jurkat T lymphocytes induced by MCF-7 cells was 95.81%, 93.16% and 91.94%, respectively. It is suggested that in breast cancers miR-21 expression is negatively associated with FasL expression, and FasL is a target gene of miR-21. miR-21 targeting and regulating FasL-mediated apoptosis will bring us the possibility of a new tumor immunotherapy via breaking tumor immune privilege.

Keywords

tumor immunotherapy / breast tumor / FasL / miR-21

References

[1] StrandS, HofmannWJ, HugH, et al.. Lymphocyte apoptosis induced by CD 95 (APO-1/Fas) ligand-expressing tumor cells—a mechanism of immune evasion?. Nat Med, 1996, 2(12): 1361-1366

[2] RyanAE, ShanahanF, O’ConnellJ, et al.. Fas ligand promotes tumor immune evasion of colon cancer in vivo. Cell Cycle, 2006, 5(3): 246-249

[3] MüschenM, MoersC, WarskulatU, et al.. CD95 ligand expression as a mechanism of immune escape in breast cancer. Immunology, 2000, 99(1): 69-77

[4] ReimerT, HerrnringC, KoczanD, et al.. FasL:Fas ratio—a prognostic factor in breast carcinomas. Cancer Res, 2000, 60(4): 822-828

[5] O’ConnellJ, BennettMW, O’SullivanGC, et al.. The Fas counterattack: cancer as a site of immune privilege. Immunol Today, 1999, 20(1): 46-52

[6] GriffithTS, BrunnerT, FletcherSM, et al.. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science, 1995, 270(5239): 1189-1192

[7] UngefrorenH, VossM, JansenM, et al.. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis. Cancer Res, 1998, 58(8): 1741-1749

[8] ZhangW, DingEX, WangQ, et al.. Fas ligand expression in colon cancer: a possible mechanism of tumor immune privilege. World J Gastroenterol, 2005, 11(23): 3632-3635

[9] SayedD, HeM, HongC, et al.. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem, 2011, 285(26): 20281-20290

[10] SayedD, RaneS, LypowyJ, et al.. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell, 2008, 19(8): 3272-3278

[11] ChaoTF, XiongHH, LiuW, et al.. MiR-21 mediates the radiation resistance of glioblastoma cells by regulating PDCD4 and hMSH2. J Huazhong Univ Sci Technol [Med Sci], 2013, 33(4): 525-552

[12] WangX, LiuY, ChenX, et al.. Impact of MiR-21 on the expression of FasL in the presence of TGF-β1. Aesthet Surg J, 2013, 33(8): 1186-1198

[13] WangN, ZhangCQ, HeJH, et al.. MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. Dig Dis Sci, 2013, 58(7): 1863-1870

[14] WangP, ZhuangL, ZhangJ, et al.. The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL. Mol Oncol, 2013, 7(3): 334-345

[15] ZhangL, DongLY, LiYJ, et al.. miR-21 represses FasL in microglia and protects against microglia-mediated neuronal cell death following hypoxia/ischemia. Glia, 2012, 60(12): 1888-1895

[16] BuscagliaLE, LiY. Apoptosis and the target genes of microRNA-21. Chin J Cancer, 2011, 30(6): 371-380